The expression of proinflammatory cytokines in the rat muscle flap with ischemia-reperfusion injury

Annals of Plastic Surgery

Volumn 54, Issue 3, 2005, Pages 313-317

  Zhang, Feng ^a   Hu, Eric C ^a   Gerzenshtein, Jacob ^a   Lei, Man Ping ^a   Lineaweaver, William C ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Cytokine; Ischemia; Muscle; Reperfusion; Surgical flap

Indexed keywords

COMPLEMENTARY DNA; CYTOKINE; INTERLEUKIN 1BETA; MESSENGER RNA; PLATELET DERIVED GROWTH FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GRACILIS MUSCLE; INFLAMMATION; ISCHEMIA; MALE; MICROSURGERY; MUSCLE FLAP; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CYTOKINES; GENE EXPRESSION; MALE; MUSCLE, SKELETAL; PLATELET-DERIVED GROWTH FACTOR; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURGICAL FLAPS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 14044261309     PISSN: 01487043     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.sap.0000146873.35098.9b     Document Type: Article

References (57)

1. Pang CY, Forrest CR, Mounsey R. Pharmacologic intervention in ischemia-induced reperfusion injury in the skeletal muscle. Microsurgery. 1993;14:176-182.
2. Lee HT, Lineaweaver WC. Protection against ischemic-reperfusion injury of skeletal muscle: role of ischemic preconditioning and adenosine pretreatment. J Reconstr Microsurg. 1996;12:383-388.
3. Kako KJ. Free radical effects on membrane protein in myocardial ischemia/reperfusion injury. J Mol Cell Cardiol. 1987;19:209-211.
4. Kerrigan CL, Stotland MA. Ischemia reperfusion injury: a review. Microsurgery. 1993;14:165-175.
5. Jordan JE, Zhao ZQ, Vinten-Johansen J. The role of neutrophils in myocardial ischemia-reperfusion injury. Cardiovasc Res. 1999;43:860-878.
6. Smith JK, Grisham MB, Granger DN, et al. Free radical defense mechanisms and neutrophil infiltration in postischemic skeletal muscle. Am J Physiol. 1989;256:H789-793.
7. Lee C, Kerrigan CL, Tellado JM. Altered neutrophil function following reperfusion of an ischemic myocutaneous flap. Plast Reconstr Surg. 1992;89:916-923.
8. Schlag MG, Harris KA, Potter RF. Role of leukocyte accumulation and oxygen radicals in ischemia-reperfusion-induced injury in skeletal muscle. Am J Physiol Heart Circ Physiol. 2001;280:H1716-1721.
9. Ono SJ, Nakamura T, Miyazaki D, et al. Chemokines: roles in leukocyte development, trafficking, and effector function. J Allergy Clin Immunol. 2003;111:1185-1199.
10. Stadelmann WK, Digenis AG, Tobin GR. Physiology and healing dynamics of chronic cutaneous wounds. Am J Surg 1998;176:26S-38S
11. Steed DL. The role of growth factors in wound healing. Surg Clin North Am. 1997;77:575-586.
12. Toledo-Pereyra LH, Suzuki S. Neutrophils, cytokines, and adhesion molecules in hepatic ischemia and reperfusion injury. J Am Coll Surg. 1994;179:758-762.
13. Valen G. Cellular signalling mechanisms in adaptation to ischemia-induced myocardial damage. Ann Med. 2003;35:300-307.
14. Serracino-Inglott F, Habib NA, Mathie RT. Hepatic ischemia-reperfusion injury. Am J Surg. 2001;181:160-166.
15. Ferrari R. The role of TNF in cardiovascular disease. Pharmacol Res. 1999;40:97-105.
16. Laskowski I, Pratschke J, Wilhelm MJ, et al. Molecular and cellular events associated with ischemia/reperfusion injury. Ann Transplant. 2000;5:29-35.
17. Das UN. Free radicals, cytokines and nitric oxide in cardiac failure and myocardial infarction. Mol Cell Biochem. 2000;215:145-152.
18. Okaya T, Lentsch AB. Cytokine cascades and the hepatic inflammatory response to ischemia and reperfusion. J Invest Surg. 2003;16:141-147.
19. Kroll SS, Schusterman MA, Reece GP, et al. Timing of pedicle thrombosis and flap loss after free-tissue transfer. Plast Reconstr Surg. 1996; 98:1230-1233.
20. Hui KC, Zhang F, Shaw WW, et al. Assessment of the patency of microvascular venous anastomosis. J Reconstr Microsurg. 2002;18:111-114.
21. Yim KK, Lineaweaver WC, Siko PP, et al. Microvascular transfer of anterior and posterior gracilis muscles in rats. Microsurgery. 1991;12: 262-267.
22. Yim K, Lineaweaver W, Briones R, et al. Critical ischemia time of rat serratus anterior and gracilis muscles. In: Carraro U, Salmon S, eds. Basic and Applied Myology: Perspectives for the 90's. Padova; 1991: 373-375.
23. Kryger Z, Dogan T, Zhang F, et al. Effects of VEGF administration following ischemia on survival of the gracilis muscle flap in the rat. Ann Plast Surg. 1999;43:172-178.
24. Mellow CG, Knight ICR, Angel MF, et al. The biochemical basis of secondary ischemia. J Surg Res. 1992;52:226-232.
25. Kerrigan CL, Zeit RG, Daniel RK. Secondary critical ischemia time of experimental skin flaps. Plast Reconstr Surg. 1984;74:522-526.
26. Mellow CG, Knight KR, Angel MF, et al. The effect of thromboxane synthetase inhibition on tolerance of skin flaps to secondary ischemia caused by venous obstruction. Plast Reconstr Surg. 1990;86:329-334.
27. Grisham MB, Hernandez LA, Granger DN. Xanthine oxidase and neutrophil infiltration in intestinal ischemia. Am J Physiol. 1986;251:G567-574.
28. Smith JK, Grisham MB, Granger DN, et al. Free radical defense mechanisms and neutrophil infiltration in postischemic skeletal muscle. Am J Physiol. 1989;256:H789-793.
29. Matsuo Y, Onodera H, Shiga Y, et al. Correlation between myeloperoxidase-quantified neutrophil accumulation and ischemic brain injury in the rat: effects of neutrophil depletion. Stroke. 1994;25:1469-1475.
30. Vedder NB, Fouty BW, Winn RK, et al. Role of neutrophils in generalized reperfusion injury associated with resuscitation from shock. Surgery. 1989;106:509-516.
31. Belkin M, LaMorte WL, Wright JG, et al. The role of leukocytes in the pathophysiology of skeletal muscle ischemic injury. J Vasc Surg. 1989; 10:14-18.
32. Eppinger MJ, Jones ML, Deeb GM, et al. Pattern of injury and the role of neutrophils in reperfusion injury of rat lung. J Surg Res. 1995;58: 713-718.
33. Cetinkale O, Bilgic L, Bolayirli M, et al. Involvement of neutrophils in ischemia-reperfusion injury of inguinal island skin flaps in rats. Plast Reconstr Surg. 1998;102:153-160.
34. Kirschner RE, Chiao JJ, Fyfe BS, et al. Neutrophil lipoxygenase activation and leukosequestration in postischemic myocutaneous flaps: role of LTB4. Am J Physiol 1995;268:H2167-2174.
35. Rumalla VK, Borah GL. Cytokines, growth factors, and plastic surgery. Plast Reconstr Surg. 2001;108:719-733.
36. Ambrosio G, Tritto I. Reperfusion injury: experimental evidence and clinical implications. Am Heart J. 1999;138:S69-75.
37. Gamble JR, Harlan JM, Klebanoff SJ, et al. Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor. Proc Natl Acad Sci USA. 1985;82:8667-8671.
38. Kang KJ. Mechanism of hepatic ischemia/reperfusion injury and protection against reperfusion injury. Transplant Proc. 2002;34:2659-2661.
39. Donnahoo KK, Shames BD, Harken AH, et al. Review article: the role of tumor necrosis factor in renal ischemia-reperfusion injury. J Urol. 1999;162:196-203.
40. Stricter RM, Kunkel SL, Bone RC. Role of tumor necrosis factor-alpha in disease states and inflammation. Crit Care Med. 1993;21:5447-463.
41. Ozer K, Adanali G, Siemionow M. Late effects of TNF-alpha-induced inflammation on the microcirculation of cremaster muscle flaps under intravital microscopy. J Reconstr Microsurg. 2002;18:37-45.
42. Adanali G, Ozer K, Siemionow MM. Acute alterations in muscle flap microcirculation during tumor necrosis factor alpha-induced inflammation. Ann Plast Surg. 2001;47:652-659.
43. Estrov Z, Kurzrock R, Talpaz M. Interleukin-1 and its inhibitors: implications for disease biology and therapy. Cancer Treat Res. 1995; 80:51-82.
44. Stewart RJ, Marsden PA. Biologic control of the tumor necrosis factor and interleukin-1 signaling cascade. Am J Kidney Dis. 1995;25:954-966.
45. Furuichi K, Wada T, Yokoyama H, et al. Role of cytokines and chemokines in renal ischemia-reperfusion injury. Drug News Perspect. 2002;15:477-482.
46. Nose PS. Cytokines and reperfusion injury. J Card Surg. 1993;8:305-308.
47. Most D, Hoyt J, Sibley RK, et al. Parenchymal cytokine expression precedes clinically observed ischemia in dorsal flaps in the rat. Plast Reconstr Surg. 1996;98:856-861.
48. Deuel TF, Kawahara RS, Mustoe TA, et al. Growth factors and wound healing: platelet-derived growth factor as a model cytokine. Annu Rev Med. 1991;42:567-584.
49. Uhl E, Rosken F, Sirsjo A, et al. Influence of platelet-derived growth factor on microcirculation during normal and impaired wound healing. Wound Repair Regen. 2003;11:361-367.
50. Nakagawa T, Sasahara M, Haneda M, et al. Role of PDGF B-chain and PDGF receptors in rat tubular regeneration after acute injury. Am J Pathol. 1999;155:1689-1699.
51. Krupinski J, Issa R, Bujny T, et al. A putative role for platelet-derived growth factor in angiogenesis and neuroprotection after ischemie stroke in humans. Stroke. 1997;28:564-573.
52. Carroll CM, Carroll SM, Schuschke DA, et al. Augmentation of skeletal muscle flap survival using platelet derived growth factor. Plast Reconstr Surg. 1998;102:407-415.
53. Hijjawi J, Mogford JE, Chandler LA, et al. Platelet-derived growth factor B, but not fibroblast growth factor 2, plasmid DNA improves survival of ischemic myocutaneous flaps. Arch Surg. 2004;139:142-147.
54. Wang C, Kerrigan CL, Stotland MA. Kinetics of E-selectin expression in surgical flaps. Plast Reconstr Surg. 1997;100:1482-1488.
55. Stotland MA, Kerrigan CL. E- and L-selectin adhesion molecules in musculocutaneous flap reperfusion injury. Plast Reconstr Surg. 1997; 99:2010-2020.
56. Chang J, Thunder R, Most D, et al. Studies in flexor tendon wound healing: neutralizing antibody to TGF-beta1 increases postoperative range of motion. Plast Reconstr Surg. 2000;105:148-155.
57. Kryger GS, Kryger Z, Zhang F, et al. Nerve growth factor inhibition prevents traumatic neuroma formation in the rat. J Hand Surg [Am]. 2001;26:635-644.